Esophageal Dysphagia Market

Growing number of smokers is driving the market growth

Market CAGR for esophageal dysphagia is driven by the rising number of smokers. The growing number of smokers is expected to impact the market's expansion during the projected time. Dysphagia is one of the most severe side effects of long-term cigarette smoking.  For instance, the World Health Organisation (WHO), a  public health organization headquartered in Switzerland, estimates that by May 2022, tobacco will be a factor in more than 8 million deaths annually.

More than 7 million fatalities are due to direct tobacco use, whereas around 1.2 million are from non-smokers exposed to secondhand smoke.  While smoking causes the deaths of almost 6 million people annually, the market for esophageal dysphagia is steadily growing because of the increasing incidence of oropharyngeal cancer.

The primary factor influencing the growth rate of the esophageal dysphagia market is the rise in healthcare spending, which aids in constructing its infrastructure. The market for esophageal dysphagia will expand due to increased awareness-raising efforts by public and private organizations. the rising need for dysphagia management in healthcare services and medical institutions, and the increase in disposable money. One of the major elements driving the  market is the growing number of smokers who will develop addictions throughout the forecast period. The rising prevalence of dysphagia, particularly among older people, drives the demand for esophageal dysphagia.

The market is expanding because of the development of cutting-edge dysphagia management techniques such as video fluoroscopy systems, neuromuscular electrical stimulation devices, and fiberoptic endoscopic evaluation of swallowing (FEES) systems. Thus, driving the esophageal dysphagia market revenue.

The Global Esophageal Dysphagia Market Industry is witnessing a surge in emerging treatment options, including pharmacological therapies and minimally invasive surgical procedures. Innovations in drug development are leading to the introduction of new medications that target the underlying causes of dysphagia, while advancements in surgical techniques are providing patients with safer and more effective solutions. This diversification of treatment modalities is likely to attract a broader patient base, thereby expanding the market. As the industry evolves, the integration of these new options is expected to enhance patient outcomes and satisfaction.

The aging population is a crucial driver of the Global Esophageal Dysphagia Market Industry. As individuals age, the risk of developing dysphagia increases due to age-related physiological changes and comorbidities. Reports suggest that approximately 30 to 40 percent of elderly individuals experience swallowing difficulties, which can lead to malnutrition and aspiration pneumonia. This demographic shift is expected to contribute to the market's expansion, with projections indicating a market value of 3.62 USD Billion by 2035. The increasing need for specialized care and tailored treatment options for the elderly population will likely stimulate demand within the industry.

Rising awareness and education regarding esophageal dysphagia are pivotal in shaping the Global Esophageal Dysphagia Market Industry. Healthcare campaigns aimed at educating both patients and providers about the symptoms and consequences of dysphagia are becoming more prevalent. This heightened awareness encourages individuals to seek medical advice sooner, leading to earlier diagnosis and treatment. Consequently, the market is expected to benefit from this trend, as more patients are identified and treated for dysphagia. The emphasis on patient education may also drive the development of new therapies and interventions, further enhancing market growth.

Technological advancements in diagnostic tools are significantly influencing the Global Esophageal Dysphagia Market Industry. Innovations such as high-resolution manometry and endoscopic ultrasound have improved the accuracy of diagnosing dysphagia. These technologies enable healthcare professionals to identify underlying causes more effectively, leading to timely interventions. As a result, the market is poised for growth, with an anticipated compound annual growth rate (CAGR) of 5.44% from 2025 to 2035. Enhanced diagnostic capabilities not only facilitate better patient outcomes but also encourage healthcare providers to adopt new treatment modalities, thereby expanding the market.

The Global Esophageal Dysphagia Market Industry is experiencing growth due to the increasing prevalence of esophageal disorders. Conditions such as gastroesophageal reflux disease (GERD) and esophageal cancer are becoming more common, leading to a higher incidence of dysphagia. For instance, studies indicate that approximately 15 to 20 percent of adults experience GERD, which can lead to swallowing difficulties. This trend is expected to drive the market, with projections estimating the market value to reach 2.02 USD Billion in 2024. As awareness of these conditions grows, the demand for effective treatment options is likely to rise, further propelling the market forward.

By region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American esophageal dysphagia market area will dominate this market. The rising prevalence of gastrointestinal illnesses, favorable reimbursement practices, an aging population, and the presence of sizable market participants are the primary drivers of the enormous market size in North America. According to an article, GERD affects 18.1% to 27.8% of individuals annually in the United States, making it the most common digestive disorder.

Further, the major countries studied in the market report are US, Canada, France, German, Italy, UK, Spain, Japan, China, Australia, India, South Korea, and Brazil.

Figure 2  ESOPHAGEAL DYSPHAGIA MARKET SHARE BY REGION 2022 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe’s esophageal dysphagia market accounts for the second-largest market share. The acceptance of endoscopic operations in this area is driven by the growing senior population and those predisposed to many chronic illnesses. One of the key elements further encouraging market expansion in the region is the increasing government measures to modernize healthcare facilities. Further, the German esophageal dysphagia market held the largest market share, and the UK esophageal dysphagia market was the rapidly growing market in the European region.

The Asia-Pacific Esophageal Dysphagia Market is expected to grow at the fastest CAGR from 2024 to 2032. The area has a sizable unmet need for facilities to treat digestive illnesses, and patient awareness of these facilities is growing, particularly in developing countries like India, China, and Indonesia. As a result, product demand is anticipated to rise throughout the forecasted period. Moreover, China’s esophageal dysphagia market held the largest market share, and the Indian esophageal dysphagia market was the rapidly growing market in the Asia-Pacific region.

Leading market players are largely investing in research and development to expand their product lines, which will help the esophageal dysphagia market, grow even more. The launch of new products, larger-scale mergers and acquisitions, contractual agreements, and collaboration with other organizations are significant market developments in which market participants engage to increase their  presence. The esophageal dysphagia industry must provide affordable products to expand and thrive in a more competitive and challenging market environment.

One of the major business strategies manufacturers use in the  esophageal dysphagia industry to increase market sector and benefit customers is local manufacturing to lower operational costs. In recent years, the esophageal dysphagia industry has stipulated some of the most important medicinal benefits.  Major players in the esophageal dysphagia industry, including Nestlé Health Science France, AstraZeneca Plc, Cook Medical Incorporated, Cipla Ltd, Merck Sharp & Dohme Corp, and others, are funding operations for research and development to boost market demand.

Since 1987, Thick-It quick food thickening products have changed how people think about food and dysphagia care. Their mission has been to develop safe products that optimize the daily lives of people who have suffered from dysphagia and have provided treatment to them for over twenty years. They will continue to devote themselves to developing and upgrading products that address the ever-changing needs of people with difficulty swallowing and their carers. In September 2020, Thick-It Brand announced the release of a dysphagia nutrition variety pack. The new packs include Purée Protein, Purée Vegetable, and Ready-to-Drink.

The ready-to-drink options come in IDDSI Level 2 - Mildly Thick (nectar) and IDDSI Level 3 - Moderately Thick (honey) consistencies.

Nestlé India Limited is Nestlé's Indian affiliate. Nestlé is a Swiss  corporation. The company's main office is in Gurgaon, Haryana. The products that the corporation sells include food, drinks, chocolate, and confections. Nestle, Nescafe, Perrier, Pure Life, and Purina are among its extensive product portfolio brands. In January 2023, Nestlé India introduced ThickenUp Clear, a food and beverage thickening that can aid patients suffering from swallowing difficulties, particularly oropharyngeal dysphagia. It can be given to people with difficulty swallowing due to illnesses including head and neck cancer, stroke, or Parkinson's disease, among others.

Dysphagia is a serious but underappreciated health problem that causes dehydration, malnutrition-related illnesses, and a lower quality of life.